| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.12B | -37.7% |
| Cost of Revenue | $693.1M | -8.5% |
| Gross Profit | $383.0M | -57.5% |
| R&D Expense | $188.3M | -19.5% |
| SG&A Expense | $339.5M | -2.6% |
| Operating Income | -$170.0M | -148.2% |
| Interest Expense | $37.3M | +8.1% |
| Pre-tax Income | -$219.0M | -169.7% |
| Income Tax | -$7.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $642.6M | +11.5% |
| Accounts Receivable | $159.2M | -42.0% |
| Inventory | $350.7M | -0.0% |
| Current Assets | $1.21B | -4.9% |
| Total Assets | $3.17B | +7.0% |
| Current Liabilities | $1.23B | +228.8% |
| Long-term Debt | $1.41B | +66.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.1M | -110.6% |
| Capital Expenditures | $115.8M | -48.5% |
| Investing Cash Flow | -$381.3M | -69.5% |
| Financing Cash Flow | $481.2M | +441.3% |
| Free Cash Flow | -$149.9M | -256.0% |
| -108.9% |
| Net Income | -$211.6M | -191.6% |
| EPS (Basic) | -$4.22 | -197.7% |
| EPS (Diluted) | -$4.22 | -198.8% |
| Total Liabilities |
| $1.78B |
| +32.7% |
| Stockholders' Equity | $1.39B | -14.3% |